CLINDAMYCIN PHOSPHATE
| Brand name | EVOCLIN |
|---|---|
| Active ingredient | CLINDAMYCIN PHOSPHATE |
| Strength | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | AEROSOL, FOAM |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | October 2004 |
| Marketing status | DISCN |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.